<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://wiki1.b.seossd.bitactive.com/index.php?action=history&amp;feed=atom&amp;title=Why_My_Xarelto_Lawsuit_Is_Better_Than_Yours</id>
		<title>Why My Xarelto Lawsuit Is Better Than Yours - Revision history</title>
		<link rel="self" type="application/atom+xml" href="http://wiki1.b.seossd.bitactive.com/index.php?action=history&amp;feed=atom&amp;title=Why_My_Xarelto_Lawsuit_Is_Better_Than_Yours"/>
		<link rel="alternate" type="text/html" href="http://wiki1.b.seossd.bitactive.com/index.php?title=Why_My_Xarelto_Lawsuit_Is_Better_Than_Yours&amp;action=history"/>
		<updated>2026-06-18T00:01:54Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.29.0</generator>

	<entry>
		<id>http://wiki1.b.seossd.bitactive.com/index.php?title=Why_My_Xarelto_Lawsuit_Is_Better_Than_Yours&amp;diff=139130&amp;oldid=prev</id>
		<title>LouveniaKantor at 20:51, 20 April 2018</title>
		<link rel="alternate" type="text/html" href="http://wiki1.b.seossd.bitactive.com/index.php?title=Why_My_Xarelto_Lawsuit_Is_Better_Than_Yours&amp;diff=139130&amp;oldid=prev"/>
				<updated>2018-04-20T20:51:42Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&#039;diff-marker&#039; /&gt;
				&lt;col class=&#039;diff-content&#039; /&gt;
				&lt;col class=&#039;diff-marker&#039; /&gt;
				&lt;col class=&#039;diff-content&#039; /&gt;
				&lt;tr style=&#039;vertical-align: top;&#039; lang=&#039;en&#039;&gt;
				&lt;td colspan=&#039;2&#039; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&#039;2&#039; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Revision as of 20:51, 20 April 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Our attorneys have filed a mass tort lawsuit on behalf of &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;patients &lt;/del&gt;who took the blood thinner Xarelto (rivaroxaban) and suffered &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;critical &lt;/del&gt;bleeding events. Pharmaceutical &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;organizations&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;which includes &lt;/del&gt;the makers of Xarelto, have a duty to make sure that their drugs are reasonably &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;secure &lt;/del&gt;for use - and failure to perform so &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;might &lt;/del&gt;be grounds for compensation. Our lawyers are functioning &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;challenging &lt;/del&gt;to obtain &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;these &lt;/del&gt;hurt by the drug the compensation they may be entitled to.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Although bleeding is really a &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;frequent &lt;/del&gt;complication &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;linked &lt;/del&gt;with anticoagulants, it has been alleged that Xarelto is &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;much &lt;/del&gt;more &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;unsafe &lt;/del&gt;than &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;conventional &lt;/del&gt;blood thinners &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;since &lt;/del&gt;no antidote exists to reverse its blood-thinning effects. This &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;signifies &lt;/del&gt;that, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;within &lt;/del&gt;the &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;occasion &lt;/del&gt;of an emergency, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;individuals &lt;/del&gt;may be at &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;threat &lt;/del&gt;for irreversible bleeding &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;issues&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;which includes &lt;/del&gt;life-threatening internal and gastrointestinal hemorrhaging.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;In case &lt;/del&gt;you or &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;possibly &lt;/del&gt;a loved one suffered a &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;critical &lt;/del&gt;bleeding &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;event soon &lt;/del&gt;after taking Xarelto, you may have legal recourse. For &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;a lot &lt;/del&gt;more &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;info&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;make &lt;/del&gt;contact &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;with &lt;/del&gt;us &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;today &lt;/del&gt;to have your case reviewed, free &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;of charge &lt;/del&gt;of charge.&amp;lt;br&amp;gt;Compensation Possibilities&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;xarelto-compensation-photoThe plaintiffs in these lawsuits are &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;looking for &lt;/del&gt;compensation from Bayer and Janssen for &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;previous &lt;/del&gt;and future &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;healthcare &lt;/del&gt;bills, lost wages, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;pain &lt;/del&gt;and suffering and, in &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;cases &lt;/del&gt;of death, funeral &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;expenses&lt;/del&gt;. In addition, they are &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;searching for &lt;/del&gt;punitive damages, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;that &lt;/del&gt;are &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;generally &lt;/del&gt;awarded to punish the defendant and deter other &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;organizations &lt;/del&gt;from acting similarly.&amp;lt;br&amp;gt;Why Are Lawsuits Being Filed?&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;harmful &lt;/del&gt;and defective. The plaintiffs claim that, unlike &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;conventional &lt;/del&gt;anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Simply because &lt;/del&gt;of this, the lawsuits claim, doctors have no effective &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;implies &lt;/del&gt;of stopping Xarelto users from bleeding &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;within &lt;/del&gt;the &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;event &lt;/del&gt;of an emergency. Plaintiffs in the lawsuits allege &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;critical &lt;/del&gt;and fatal injuries, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;[https://twitter.com/search?q=including%20cerebral&amp;amp;src=typd including &lt;/del&gt;cerebral&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;] &lt;/del&gt;hemorrhaging and gastrointestinal bleeds, from use of the drug.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In addition to these risks, lawsuits against Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals are alleging:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.&amp;lt;br&amp;gt;The makers of the drug continue to market Xarelto as a &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;protected &lt;/del&gt;anticoagulant option.&amp;lt;br&amp;gt;Doctors and &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;medical &lt;/del&gt;staff were not properly made aware of methods to stabilize and treat a Xarelto user &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;inside &lt;/del&gt;the occasion of a bleeding complication.&amp;lt;br&amp;gt;Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.&amp;lt;br&amp;gt;Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach &lt;del class=&quot;diffchange diffchange-inline&quot;&gt; [http://www.norskxxx.com/2007/12/03/norsk-xxx/mitt-syn-pa-pupper-og-deres-nytteverdi/ http://www.norskxxx.com/2007/12/03/norsk-xxx/mitt-syn-pa-pupper-og-deres-nytteverdi] &lt;/del&gt;bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;dangerous &lt;/del&gt;clotting.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Visit this page for &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;far &lt;/del&gt;more &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;info &lt;/del&gt;on the alleged health risks of Xarelto.&amp;lt;br&amp;gt;Multidistrict Litigation Trial Dates Set&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The attorneys &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;within &lt;/del&gt;the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Our attorneys have filed a mass tort lawsuit on behalf of &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;sufferers &lt;/ins&gt;who took the blood thinner Xarelto (rivaroxaban) and suffered &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;significant &lt;/ins&gt;bleeding events. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;[https://www.Flickr.com/search/?q=Pharmaceutical &lt;/ins&gt;Pharmaceutical&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;] firms&lt;/ins&gt;, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;like &lt;/ins&gt;the makers of Xarelto, have a duty to make sure that their drugs are reasonably &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;protected &lt;/ins&gt;for use - and failure to perform so &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;may possibly &lt;/ins&gt;be grounds for compensation. Our lawyers are functioning &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;difficult &lt;/ins&gt;to obtain &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;those &lt;/ins&gt;hurt by the drug the compensation they may be entitled to.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Although bleeding is really a &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;widespread &lt;/ins&gt;complication &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;associated &lt;/ins&gt;with anticoagulants, it has been alleged that Xarelto is &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;far &lt;/ins&gt;more &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;dangerous &lt;/ins&gt;than &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;standard &lt;/ins&gt;blood thinners &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;simply because &lt;/ins&gt;no antidote exists to reverse its blood-thinning effects. This &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;means &lt;/ins&gt;that, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;inside &lt;/ins&gt;the &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;event &lt;/ins&gt;of an emergency, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;sufferers &lt;/ins&gt;may be at &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;danger &lt;/ins&gt;for irreversible bleeding &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;problems&lt;/ins&gt;, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;including &lt;/ins&gt;life-threatening internal and gastrointestinal hemorrhaging.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;If &lt;/ins&gt;you or &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;perhaps &lt;/ins&gt;a loved one &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;particular &lt;/ins&gt;suffered a &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;significant &lt;/ins&gt;bleeding &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;occasion right &lt;/ins&gt;after taking Xarelto, you may have legal recourse. For &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;far &lt;/ins&gt;more &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;information&lt;/ins&gt;, contact us &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;these days &lt;/ins&gt;to have your case reviewed, free of charge.&amp;lt;br&amp;gt;Compensation Possibilities&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;xarelto-compensation-photoThe plaintiffs in these lawsuits are &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;seeking &lt;/ins&gt;compensation from Bayer and Janssen for &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;past &lt;/ins&gt;and future &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;health-related &lt;/ins&gt;bills, lost wages, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;discomfort &lt;/ins&gt;and suffering and, in &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;instances &lt;/ins&gt;of death, funeral &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;expenditures&lt;/ins&gt;. In addition, they are &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;in search of &lt;/ins&gt;punitive damages, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;which &lt;/ins&gt;are &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;normally &lt;/ins&gt;awarded to punish the defendant and deter other &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;firms &lt;/ins&gt;from acting similarly.&amp;lt;br&amp;gt;Why Are Lawsuits Being Filed?&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;[http://Www.Ajaxtime.com/?s=&lt;/ins&gt;alleging &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;alleging] &lt;/ins&gt;that the drug is &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;dangerous &lt;/ins&gt;and defective. The plaintiffs claim that, unlike &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;classic &lt;/ins&gt;anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Because &lt;/ins&gt;of this, the lawsuits claim, doctors have no effective &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;indicates &lt;/ins&gt;of stopping Xarelto users from bleeding &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;in &lt;/ins&gt;the &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;occasion &lt;/ins&gt;of an emergency. Plaintiffs in the lawsuits allege &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;significant &lt;/ins&gt;and fatal injuries, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;like &lt;/ins&gt;cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In addition to these risks, lawsuits against Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals are alleging:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt; [http://help.miku.moe/index.php?title=How_I_Improved_My_Xarelto_Lawsuit_In_One_Day browse around here] &lt;/ins&gt;finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.&amp;lt;br&amp;gt;The makers of the drug continue to market Xarelto as a &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;safe &lt;/ins&gt;anticoagulant option.&amp;lt;br&amp;gt;Doctors and &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;health-related &lt;/ins&gt;staff were not properly made aware of methods to stabilize and treat a Xarelto user &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;within &lt;/ins&gt;the occasion of a bleeding complication.&amp;lt;br&amp;gt;Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.&amp;lt;br&amp;gt;Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;unsafe &lt;/ins&gt;clotting.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Visit this page for &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;much &lt;/ins&gt;more &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;information &lt;/ins&gt;on the alleged health risks of Xarelto.&amp;lt;br&amp;gt;Multidistrict Litigation Trial Dates Set&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The attorneys &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;inside &lt;/ins&gt;the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>LouveniaKantor</name></author>	</entry>

	<entry>
		<id>http://wiki1.b.seossd.bitactive.com/index.php?title=Why_My_Xarelto_Lawsuit_Is_Better_Than_Yours&amp;diff=40554&amp;oldid=prev</id>
		<title>LesUce3373: Created page with &quot;Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical organ...&quot;</title>
		<link rel="alternate" type="text/html" href="http://wiki1.b.seossd.bitactive.com/index.php?title=Why_My_Xarelto_Lawsuit_Is_Better_Than_Yours&amp;diff=40554&amp;oldid=prev"/>
				<updated>2018-04-11T13:35:55Z</updated>
		
		<summary type="html">&lt;p&gt;Created page with &amp;quot;Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical organ...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical organizations, which includes the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use - and failure to perform so might be grounds for compensation. Our lawyers are functioning challenging to obtain these hurt by the drug the compensation they may be entitled to.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Although bleeding is really a frequent complication linked with anticoagulants, it has been alleged that Xarelto is much more unsafe than conventional blood thinners since no antidote exists to reverse its blood-thinning effects. This signifies that, within the occasion of an emergency, individuals may be at threat for irreversible bleeding issues, which includes life-threatening internal and gastrointestinal hemorrhaging.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In case you or possibly a loved one suffered a critical bleeding event soon after taking Xarelto, you may have legal recourse. For a lot more info, make contact with us today to have your case reviewed, free of charge of charge.&amp;lt;br&amp;gt;Compensation Possibilities&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in cases of death, funeral expenses. In addition, they are searching for punitive damages, that are generally awarded to punish the defendant and deter other organizations from acting similarly.&amp;lt;br&amp;gt;Why Are Lawsuits Being Filed?&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, [https://twitter.com/search?q=including%20cerebral&amp;amp;src=typd including cerebral] hemorrhaging and gastrointestinal bleeds, from use of the drug.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In addition to these risks, lawsuits against Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals are alleging:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.&amp;lt;br&amp;gt;The makers of the drug continue to market Xarelto as a protected anticoagulant option.&amp;lt;br&amp;gt;Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.&amp;lt;br&amp;gt;Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.&amp;lt;br&amp;gt;Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach  [http://www.norskxxx.com/2007/12/03/norsk-xxx/mitt-syn-pa-pupper-og-deres-nytteverdi/ http://www.norskxxx.com/2007/12/03/norsk-xxx/mitt-syn-pa-pupper-og-deres-nytteverdi] bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Visit this page for far more info on the alleged health risks of Xarelto.&amp;lt;br&amp;gt;Multidistrict Litigation Trial Dates Set&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.&lt;/div&gt;</summary>
		<author><name>LesUce3373</name></author>	</entry>

	</feed>